Latest Headlines

  1. NeoGenomics Launches PanTracer LBx, Expanding Access To Comprehensive Genomic Profiling With Liquid Biopsy 7/30/2025

    NeoGenomics, Inc., a leading provider of oncology diagnostic solutions that enable precision medicine, today announced the launch of NEO PanTracer LBx, a blood-based comprehensive genomic profiling (CGP) test, expanding the company’s PanTracer portfolio.

  2. Illumina Enhances Flagship Assay To Accelerate Access To Comprehensive Tumor Profiling 7/30/2025

    Illumina Inc. (NASDAQ: ILMN) today announced the launch of the next generation of TruSight Oncology 500, its flagship cancer research assay that enables comprehensive genomic profiling.

  3. Labcorp Introduces Test Finder, A First-Of-Its-Kind Generative AI Tool To Simplify Lab Test Search 7/30/2025

    Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today the launch of Test Finder, a first-of-its-kind generative AI tool developed with Amazon Web Services (AWS).

  4. Quansys Biosciences Launches Q-View Imager Plus: Delivering Reproducible, High-Impact ELISA Data With Ease 7/29/2025

    Quansys Biosciences, a leader in multiplex immunoassay technology, today announced the launch of the Q-View Imager Plus, a next-generation imaging device designed to deliver reproducible, high-resolution ELISA results with streamlined workflows.

  5. hc1 And Shadowbox Partner To Close Patient Care Gaps With Optimized Diagnostic Laboratory Testing 7/29/2025

    hc1, a leader in transforming actionable lab data into valuable insights that enable healthcare systems to close gaps in patient care and improve financial performance, and Shadowbox, an innovator in automation for independent labs, have announced a strategic partnership.

  6. Athena Diagnostics Improves Ataxia Movement Disorder Testing With Novel Long-Read Gene Sequencing 7/29/2025

    Athena Diagnostics, the specialty neurology business of Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, today announced a new laboratory test service intended to provide insights into genetic causes of ataxia, a group of progressive, degenerative neurological disorders that affect movement or coordination.

  7. Fapon To Debut Shine mT8000 Open-Access, High Throughput Clinical Chemistry And Immunoassay Analyzer At ADLM 2025 7/29/2025

    Fapon, a global leading life sciences company, will debut its Shine mT8000 Fully Automated Clinical Chemistry and Immunoassay System at the ADLM 2025 Annual Scientific Meeting. 

  8. Panome Bio Multi-Omics Laboratory Enhances Clinical Capabilities With CLIA Certification 7/29/2025

    Panome Bio, a leader in advanced proteomic, metabolomic and transcriptional profiling technologies, announced it has achieved Clinical Laboratory Improvement Amendments (CLIA) certification for its state-of-the-art laboratory.

  9. Thermo Fisher Scientific Showcases Diagnostics Solutions Designed To Meet Evolving Global Healthcare Demands At ADLM 2025 7/28/2025

    Thermo Fisher Scientific, the world leader in serving science, showcases its innovations in improving clinical and diagnostic laboratory efficiency and workflow optimization during the Association for Diagnostics & Laboratory Medicine Conference (ADLM), July 27-31, 2025, in Chicago, Ill.

  10. Aptitude Secures $9M Partnership With BARDA To Develop Rapid Molecular Diagnostic For Ebolaviruses And Marburg Viruses 7/28/2025

    Aptitude Medical Systems (Aptitude™) announced today its second major partnership with the Biomedical Advanced Research and Development Authority (BARDA), with $9 million in funding to develop the Metrix Filovirus Panel.